May 11-14, 2026
Hynes Convention CenterBoston, MA Athul Sanjeev, PhDAdvisor, RNA Technology and Process Development at Eli Lilly & CompanySpeaker
Profile
Athul is an Advisor in mRNA Process Development at Verve Therapeutics, a wholly owned subsidiary of Eli Lilly, where he focuses on advancing RNA-based therapeutics. He holds a Ph.D. in Chemistry from Northeastern University and brings extensive expertise in RNA and protein engineering and process development. His work spans the intersection of molecular science and bioprocess innovation, contributing to the growing field of mRNA medicines.
Agenda Sessions
Engineering T7 RNA Polymerase to Reduce Double Stranded RNA Impurities and Improve Capping Efficiency
, 11:45amView Session